Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor
- PMID: 2835420
- PMCID: PMC2188945
- DOI: 10.1084/jem.167.5.1737
Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor
Abstract
The recent molecular cloning of the complementary DNA encoding T cell--replacing factor (TRF) has demonstrated that a single molecule is responsible for B cell growth factor II (BCGF-II) activity and eosinophil differentiation activity. It has been proposed that this molecule be called interleukin 5 (IL-5). We previously reported that purified rIL-5 supports the terminal differentiation and proliferation of eosinophilic precursors. In this study, we examined the effects of IL-5 on functional activities of mature eosinophils. IL-5 maintained the viability of mature eosinophils obtained from peritoneal exudate cells of mice infected with parasites. It also induced superoxide anion production in a dose-dependent manner. The Boyden's chamber Millipore assay revealed that IL-5 had a marked chemokinetic effect on eosinophils in a dose-dependent manner. Moreover, IL-5 was found to be an eosinophil chemotactic factor by the checkerboard assay. In conclusion, IL-5 is suggested to play an important role in increasing the functional activities of eosinophils as well as their production in allergic and parasitic diseases.
Similar articles
-
Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors.J Exp Med. 1988 Jan 1;167(1):43-56. doi: 10.1084/jem.167.1.43. J Exp Med. 1988. PMID: 3257253 Free PMC article.
-
Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.Mol Med. 1996 May;2(3):334-48. Mol Med. 1996. PMID: 8784786 Free PMC article.
-
Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis.Intern Med. 1997 Mar;36(3):179-85. doi: 10.2169/internalmedicine.36.179. Intern Med. 1997. PMID: 9144009
-
T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties.Immunol Rev. 1988 Feb;102:107-35. doi: 10.1111/j.1600-065x.1988.tb00743.x. Immunol Rev. 1988. PMID: 3284812 Review.
-
Eosinophil differentiation factor (interleukin-5).Immunol Ser. 1990;49:231-56. Immunol Ser. 1990. PMID: 2090253 Review.
Cited by
-
Effects of reactive oxygen and nitrogen metabolites on RANTES- and IL-5-induced eosinophil chemotactic activity in vitro.Am J Pathol. 1999 Aug;155(2):591-8. doi: 10.1016/S0002-9440(10)65154-1. Am J Pathol. 1999. PMID: 10433951 Free PMC article.
-
L-tryptophan contaminant 'peak E' induces the release of IL-5 and IL-10 by peripheral blood mononuclear cells from patients with functional somatic syndromes.Clin Exp Immunol. 2001 Nov;126(2):187-92. doi: 10.1046/j.1365-2249.2001.01559.x. Clin Exp Immunol. 2001. PMID: 11703359 Free PMC article.
-
New Light Shed On The Enigmatic Eosinophil Granulocyte; A Versatile Cell Of The Immune System.EJIFCC. 1999 May 29;11(1):6-25. eCollection 1999 May. EJIFCC. 1999. PMID: 30720250 Free PMC article. Review.
-
Hypereosinophilia in a horse with intestinal lymphosarcoma.Can Vet J. 1997 Nov;38(11):719-20. Can Vet J. 1997. PMID: 9360792 Free PMC article.
-
Chemokines active on eosinophils: potential roles in allergic inflammation.J Exp Med. 1996 Jun 1;183(6):2421-6. doi: 10.1084/jem.183.6.2421. J Exp Med. 1996. PMID: 8676062 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources